REFERENCES
1. Roberge RJ. Face shields for infection control: A review. J Occup
Environ Hyg. 2016;13(4):235-42.
2. Lakhani R, Loh Y, Zhang TT, Kothari P. A prospective study of blood
splatter in ENT. Eur Arch Otorhinolaryngol. 2015;272(7):1809-12.
3. Chao YS, Spry C. CADTH Rapid Response Reports. The Use of N95
Respirators for Protection against Droplet Borne Illness: A Review of
the Clinical Effectiveness and Guidelines. Ottawa (ON): Canadian Agency
for Drugs and Technologies in Health
Copyright © 2017 Canadian Agency for Drugs and Technologies in Health.;
2017.
4. Broussard IM, Kahwaji CI. Universal Precautions. StatPearls. Treasure
Island (FL): StatPearls Publishing
Copyright © 2020, StatPearls Publishing LLC.; 2020.
5. Weber RT, Phan LT, Fritzen-Pedicini C, Jones RM. Environmental and
Personal Protective Equipment Contamination during Simulated Healthcare
Activities. Ann Work Expo Health. 2019;63(7):784-96.
6. Holzmann RD, Liang M, Nadiminti H, McCarthy J, Gharia M, Jones J, et
al. Blood exposure risk during procedural dermatology. J Am Acad
Dermatol. 2008;58(5):817-25.
7. Grainger. QuickTips Technical Resources: “Quick Tip #373. Face
shield Protection.” 2018 [Available from:
https://www.grainger.com/content/qt-face-shield-protection-373.
8. Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the
newly identified coronavirus 2019-nCoV. Journal of Medical Virology.
2020;92(4):433-40.
9. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel
Coronavirus from Patients with Pneumonia in China, 2019. New England
Journal of Medicine. 2020;382(8):727-33.
10. Li JO, Lam DSC, Chen Y, Ting DSW. Novel Coronavirus disease 2019
(COVID-19): The importance of recognising possible early ocular
manifestation and using protective eyewear. Br J Ophthalmol.
2020;104(3):297-8.
11. Wong J, Goh QY, Tan Z, Lie SA, Tay YC, Ng SY, et al. Preparing for a
COVID-19 pandemic: a review of operating room outbreak response measures
in a large tertiary hospital in Singapore. Can J Anaesth. 2020.
12. Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid
advice guideline for the diagnosis and treatment of 2019 novel
coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med
Res. 2020;7(1):4.
13. Schwartz J, King CC, Yen MY. Protecting Health Care Workers during
the COVID-19 Coronavirus Outbreak -Lessons from Taiwan’s SARS response.
Clin Infect Dis. 2020.
14. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial
cluster of pneumonia associated with the 2019 novel coronavirus
indicating person-to-person transmission: a study of a family cluster.
Lancet. 2020;395(10223):514-23.
15. Yu P, Zhu J, Zhang Z, Han Y, Huang L. A familial cluster of
infection associated with the 2019 novel coronavirus indicating
potential person-to-person transmission during the incubation period. J
Infect Dis. 2020.
16. Huh S. How to train the health personnel for protecting themselves
from novel coronavirus (COVID-19) infection during their patient or
suspected case care. J Educ Eval Health Prof. 2020;17:10.
17. Rational use of personal protective equipment (PPE) for coronavirus
disease (COVID-19). WHO. 19 March 2020.
18. Brewster DJ, Chrimes NC, Do TB, Fraser K, Groombridge CJ, Higgs A,
et al. Consensus statement: Safe Airway Society principles of airway
management and tracheal intubation specific to the COVID-19 adult
patient group. MJA. 16 March 2020.
19. Zhang T, Cui X, Zhao X, Wang J, Zheng J, Zheng G, et al. Detectable
SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period
of COVID-19 Pneumonia. J Med Virol. 2020.
20. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of
coronaviruses on inanimate surfaces and their inactivation with biocidal
agents. J Hosp Infect. 2020;104(3):246-51.
21. Yassi A, Moore D, Fitzgerald JM, Bigelow P, Hon CY, Bryce E.
Research gaps in protecting healthcare workers from SARS and other
respiratory pathogens: an interdisciplinary, multi-stakeholder,
evidence-based approach. J Occup Environ Med. 2005;47(1):41-50.
22. Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: A brief
perspective from the front line. J Infect. 2020;80(4):373-7.
23. Tellier R. Aerosol transmission of influenza A virus: a review of
new studies. J R Soc Interface. 2009;6 Suppl 6(Suppl 6):S783-90.
24. Bahl P, Doolan C, de Silva C, Chughtai AA, Bourouiba L, MacIntyre
CR. Airborne or droplet precautions for health workers treating
COVID-19? J Infect Dis. 2020.
25. Lindsley WG, Noti JD, Blachere FM, Szalajda JV, Beezhold DH.
Efficacy of face shields against cough aerosol droplets from a cough
simulator. J Occup Environ Hyg. 2014;11(8):509-18.
26. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A,
Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as
Compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564-7.
27. Gralton J, Tovey E, McLaws ML, Rawlinson WD. The role of particle
size in aerosolised pathogen transmission: a review. J Infect.
2011;62(1):1-13.
28. Gamage B, Moore D, Copes R, Yassi A, Bryce E. Protecting health care
workers from SARS and other respiratory pathogens: a review of the
infection control literature. Am J Infect Control. 2005;33(2):114-21.
29. Davies CG, Khan MN, Ghauri AS, Ranaboldo CJ. Blood and body fluid
splashes during surgery–the need for eye protection and masks. Ann R
Coll Surg Engl. 2007;89(8):770-2.
30. Endo S, Kanemitsu K, Ishii H, Narita M, Nemoto T, Yaginuma G, et al.
Risk of facial splashes in four major surgical specialties in a
multicentre study. J Hosp Infect. 2007;67(1):56-61.
31. Bell KM, Clement DA. Eye protection for the surgeon. J R Coll Surg
Edinb. 1991;36(3):178-9.
32. Marasco S, Woods S. The risk of eye splash injuries in surgery. Aust
N Z J Surg. 1998;68(11):785-7.
33. De Silva R, Mall A, Panieri E, Stupart D, Kahn D. Risk of blood
splashes to the eye during surgery. S Afr J Surg. 2009;47(1):7-9.
34. Keogh IJ, Hone SW, Colreavey M, Walsh M. Blood splash and
tonsillectomy: an underestimated hazard to the otolaryngologist. J
Laryngol Otol. 2001;115(6):455-6.
35. Brearley S, Buist LJ. Blood splashes: an underestimated hazard to
surgeons. Bmj. 1989;299(6711):1315.
36. Singh VK, Kalairajah Y. Splash in elective primary knee and hip
replacement: are we adequately protected? J Bone Joint Surg Br.
2009;91(8):1074-7.
37. Chong SJ, Smith C, Bialostocki A, McEwan CN. Do modern spectacles
endanger surgeons? The Waikato Eye Protection Study. Ann Surg.
2007;245(3):495-501.
38. Mansour AA, 3rd, Even JL, Phillips S, Halpern JL. Eye protection in
orthopaedic surgery. An in vitro study of various forms of eye
protection and their effectiveness. J Bone Joint Surg Am.
2009;91(5):1050-4.
39. Perlino C, Hilliard J, Koehler J. Fatal Cercopithecine herpesvirus 1
(B virus) infection following a mucocutaneous exposure and interim
recommendations for worker protection. MMWR Morb Mortal Wkly Rep.
1998;47(49):1073-6, 83.
40. Bischoff WE, Reid T, Russell GB, Peters TR. Transocular entry of
seasonal influenza-attenuated virus aerosols and the efficacy of n95
respirators, surgical masks, and eye protection in humans. J Infect Dis.
2011;204(2):193-9.
41. Hallmo P, Naess O. Laryngeal papillomatosis with human
papillomavirus DNA contracted by a laser surgeon. Eur Arch
Otorhinolaryngol. 1991;248(7):425-7.
42. Ishihama K, Sumioka S, Sakurada K, Kogo M. Floating aerial blood
mists in the operating room. J Hazard Mater. 2010;181(1-3):1179-81.
43. S. S, C. A-V, M. C, M. H. Comparison of Protection against Ocular
Contamination with Disposable Eyewear Products.
44. Loveridge JM, Gozzard C, Bannister GC. The effectiveness of a visor
as a surgical barrier: an inverted position is better. J Hosp Infect.
2006;62(2):251-3.
45. Gala CL, Hall CB, Schnabel KC, Pincus PH, Blossom P, Hildreth SW, et
al. The use of eye-nose goggles to control nosocomial respiratory
syncytial virus infection. Jama. 1986;256(19):2706-8.
46. Lau JT, Fung KS, Wong TW, Kim JH, Wong E, Chung S, et al. SARS
transmission among hospital workers in Hong Kong. Emerg Infect Dis.
2004;10(2):280-6.
47. Ng TC, Lee N, Hui SC, Lai R, Ip M. Preventing healthcare workers
from acquiring influenza. Infect Control Hosp Epidemiol.
2009;30(3):292-5.
48. Stability and Viability of SARS-CoV-2. New England Journal of
Medicine. 2020;382(20):1962-6.
49. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air,
Surface Environmental, and Personal Protective Equipment Contamination
by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a
Symptomatic Patient. Jama. 2020.
50. Kam KQ, Yung CF, Cui L, Lin Tzer Pin R, Mak TM, Maiwald M, et al. A
Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral
Load. Clin Infect Dis. 2020.
51. Kouri DL, Ernest JM. Incidence of perceived and actual face shield
contamination during vaginal and cesarean delivery. Am J Obstet Gynecol.
1993;169(2 Pt 1):312-5; discussion 5-6.
52. Kelly G, Gana P, Nielsen T, MacGregor F. The incidence of potential
conjunctival contamination in tonsillectomy. J R Coll Surg Edinb.
2000;45(5):288-90.
53. Wines MP, Lamb A, Argyropoulos AN, Caviezel A, Gannicliffe C, Tolley
D. Blood splash injury: an underestimated risk in endourology. J
Endourol. 2008;22(6):1183-7.
54. Greenland KB, Tsui D, Goodyear P, Irwin MG. Personal protection
equipment for biological hazards: does it affect tracheal intubation
performance? Resuscitation. 2007;74(1):119-26.